期刊文献+

膀胱灌注辣椒辣素类似物治疗特发性膀胱过度活动症随机对照临床研究 被引量:1

Intravesical instillation resiniferatoxin for the treatment of patients with idiopathic overactive bladder:a randomized,placebo controlled clinical trial
原文传递
导出
摘要 目的探讨膀胱灌注辣椒辣素类似物(RTX)治疗特发性膀胱过度活动症(IOAB)的临床效果。方法IOAB患者26例随机分为试验A组和对照B组。A组14例,用100 nmol/L RTX 100 ml灌注膀胱保留30 min后排空。B组12例,用1∶5 000呋喃西林(安慰剂)替代RTX,方法同A组。观察A,B两组用药前、用药后1个月、用药后3个月的临床症状(每日排尿次数、尿急程度)和尿动力学参数(FDV、MCBC、Qmax)。结果治疗前与治疗后1个月、3个月的临床症状和尿动力学参数比较,A组差异有显著意义(P<0.01),B组差异无显著意义(P>0.05)。14/26例(54%)有轻度尿道刺激症状或膀胱区不适,均可耐受。结论RTX单剂量膀胱灌注能安全有效地改善IOAB临床症状和尿动力学指标。 Objective To evaluated the clinical outcomes of intravesical instillation resiniferatoxin(RTX) for the treatment of patients with idiopathic overactive bladder(IOAB). Methods 26 cases with IOAB were randomly divided into test(A, 14 cases) and control(B, 12 cases) groups. The patients in group A were treated by intravesical instillation with 40ml of 0.5 96 idocain retained within the bladder for 3 minutes at first and with 100ml of 100nmol/L RTX retained within the bladder for 30 minutes late. The patients in group B were treated by the same method, however,the furacilin solution(placebo) at a dilution 1:5000 was used instead of 100nmol/L RTX. The efficacy(daily voiding frequency,urgent uresis,FDV, MCBC, Qmax) of the 2 groups were evaluated before, 1 month and 3 months after treatment. Results The pre-treatment comparion with prost-treatmen at 1 month and 3 months of A group was significant(P 〈 0.01 ), and B group was not significant( P 〉 0.05 ). 14 patients(54 96 ) had slightly stimulating symptom in the urethra or bladder, and were otherwise generally well tolerated. Conclusion Single administration of RTX is safe and effective in patients with IOAB.
出处 《中国基层医药》 CAS 2006年第2期225-226,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 膀胱过度活动症 辣椒辣素类似物 随机对照试验 膀胱灌注 特发性膀胱过度活动症 Overactive bladder Resiniferatoxin Randomized controlled clinical trial
  • 相关文献

参考文献9

  • 1Beneton C, De Parisot O. Le traitement medical de l' hyperactivite vesicale. Neurochirurgie,2003.49(2-3 Pt 2) :369-376.
  • 2Andersson KE. Advances in the pharmacological control of the bladder. Exp Physiol, 1999,84 ( 1 ) : 195-213.
  • 3Yoshimura N, De Groat WC. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci, 1999,19 ( 11 ) : 4644 -4653.
  • 4Yoshimura N. Bladder afferent pathway and spinal cord iniury:possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol, 1999,57 (6) : 583-606.
  • 5Cruz F. Mechanisms involved in new therapies for overactive bladder. Urology, 2004,63 (3 Suppl 1 ) : 65 -73.
  • 6Silva C, Ribeiro MJ,Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol,2002,168(2) :575-579.
  • 7Szallasi A. Vanilloid(capsaicin) receptors in health and disease. Am J Clin Pathol,2002,118(1) :110-121.
  • 8Yamaguchi O. Pathophysiology of the overactive bladder and its pharmacological treatment. Nippon Yakurigaku Zasshi, 2003. 121(5) :331-338.
  • 9Payne CK. Mosbaugh PG, Forrest JB, et al. lntravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized,doubleblind.placebo controlled trial. J Urol,2005.173(5) 1590-1594.

同被引文献17

  • 1梅红兵,杜光辉,叶章群,邢玮,陈春莲.生长相关蛋白-43在膀胱过度活动症患者膀胱表达的研究[J].中国医师杂志,2006,8(6):724-727. 被引量:4
  • 2Kumar V,Cross RL,Chess-Williams R,et al.Recent advances in basic science for overactive bladder.Curr Opin Urol,2005,15(4):222-226.
  • 3Scott VE,Davis-Taber RA,Silvia C,et al.Characterization of human urinary bladder KATP channels containing SUR2 B splice variants expressed in L-cells.Eur J Pharmacol,2004,483 (2/3):195-205.
  • 4Badawi JK,Langbein S.Selective beta-adrenoceptor agonists,calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence.Pharmazie,2006,61(3):175-178.
  • 5Elzayat E,Khaled S,Kashiwabara T,et al.Effect of the potassium channel opener WAY-133537 on the overactive bladder of spinalized rats.Neurourol Urodyn,2006,25(7):808-814.
  • 6Fey TA,Gopalakrishnan M,Strake JG,et al.Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction.Neurourol Urodyn,2003,22(2):147-155.
  • 7Giannantoni A,Rossi A,Mearini E,et al.Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy.J Urol,2009,182(4):1453-1457.
  • 8Lin AT,Yang CH,Chen KK,et al.Detrusor mitochondrial lipid peroxidation and superoxide dismutase activity in partial bladder outlet obstruction of rabbits.Neurourol Urodyn,2005,24 (3):282-287.
  • 9Thomeloe KS,Nelson MT.Properties and molecular basis of the mouse urinary bladder voltage-gated K+ current.J Physiol,2003,54Pt1:65-74.
  • 10Amberg GC,Baker SA,Koh SD,et al.Characterization of the A-type potassium current in murine gastric antrum.J Physiol,2008,544 Pt 2:417-428.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部